Q/C Technologies, Inc.

QCLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $1.6M $1.7M $3.4M $3.0M $2.1M $4.4M $3.6M
Cost of Revenue $46.5K $93.6K $136.1K $138.7K $115.4K $71.4K $1.9M
Gross Profit $478.7K $127.3K $948.6K $1.9M $1.2M $3.3M $1.7M
Gross Margin 30.4% 7.6% 28.3% 63.4% 55.0% 73.5% 46.5%
Operating Expenses
Research & Development $276.8K $1.1M $1.3M $1.2M $1.4M $916.3K $1.0M
SG&A Expense $3.4M $5.7M $4.1M $3.0M $4.0M $3.8M $1.1M
Operating Income $-3.5M $-10.1M $-6.6M $-3.3M $-9.7M $-3.2M $-1.8M
Operating Margin -220.2% -604.0% -197.1% -112.4% -457.8% -72.4% -50.6%
Interest Expense
Pretax Income $-3.4M $-10.8M $-7.4M $-3.3M $-9.6M $-3.1M $-1.5M
Income Tax Expense $-269.3K
Net Income $-3.9M $-10.8M $-7.4M $-3.3M $-9.3M $-3.1M $-1.5M
Net Margin -246.6% -651.4% -219.6% -111.6% -440.3% -71.0% -42.7%
EPS (Basic) $-0.09 $-0.32 $-0.09 $-0.01 $-0.03 $-0.01 $-0.01
EPS (Diluted) $-0.09 $-0.32 $-0.09 $-0.01 $-0.03 $-0.01 $-0.01
Shares Outstanding (Basic) 120.0M 37.3M 381.9M 376.2M 374.3M 341.9M 149.6M
Shares Outstanding (Diluted) 120.0M 37.3M 381.9M 376.2M 374.3M 341.9M 149.6M
Dividends Per Share